US 11135226
Use of reboxetine to treat narcolepsy
granted A61KA61K31/5375A61P
Quick answer
US patent 11135226 (Use of reboxetine to treat narcolepsy) held by AXSOME THERAPEUTICS, INC. expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AXSOME THERAPEUTICS, INC.
- Grant date
- Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/5375, A61P, A61P25/02, A61P25/20